TRANSITIONAL CELL CARCINOMA
Clinical trials for TRANSITIONAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSITIONAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Three-Drug attack on Tough-to-Treat bladder cancer
Disease control OngoingThis study is testing a new combination of three drugs for advanced bladder cancer that has spread or cannot be surgically removed. The first part aims to find the safest and most effective doses. The second part will see how well the chosen dose combination works to shrink tumor…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC